Gilead Sciences, Inc. (NASDAQ:GILD) Chief Medical Officer Merdad Parsey has recently engaged in significant trading activity, according to the latest filings with the Securities and Exchange ...

Gilead Sciences, Inc. (NASDAQ:GILD) Chief Medical Officer Merdad Parsey has recently engaged in significant trading activity, according to the latest filings with the Securities and Exchange ...

Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series of high-profile departures involving senior R&D figures at top drugmakers.

Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $81.44 which represents a slight increase of $2.27 or 2.87% from the prior close of $79.17. The stock opened at $79.17 and ...

"This is a significant milestone for Gilead and, more importantly, for patients diagnosed with these cancers," said the company's chief medical officer Merdad Parsey. "We look forward to ...

Adds He Is Safe After Shooting Incident at Florida Golf Course A campaign spokesman said there had been gunshots in former President Trump’s “vicinity.” A person of interest was detained, a ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.

Sep. 12, 2024 — Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the ... Facemask Impacts Are ...